FOLH1 and prostate cancer: The cohort consisted of 56 patients diagnosed with prostate cancer (36 primary, 20 BCR) who underwent [68 Ga]Ga-PSMA-11 LFOV PET/CT imaging at two distinct time points: 1-h p.i. and 3-h p.i..